logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/05/2025
Coinbase stock price increased by 2%.
Latest
9 m ago
"Off-exchange options + spot services" bidirectional empowerment innovative model to solve the operational difficulties of physical enterprises.
10 m ago
Two radar malfunctions in half a month prompt U.S. officials to consider reducing the number of flights at Newark Airport.
12 m ago
Nanhua Futures' Sprint Behind "H Shares": Can International Business Reshape Industry Competition Pattern?
12 m ago
The commercialization process is accelerating, and investment opportunities in the exoskeleton robot industry chain are becoming more prominent.
15 m ago
UBS maintains its rating on Celldex Therapeutics (CLDX.US) and adjusts its rating from Buy to Buy, with a target price adjusted from $44.00 to $38.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.